SUMMARY The value of serum creatine kinase B subunit activity (CK B) in the diagnosis of acute myocardial infarction was studied in 238 consecutive cases. All were admitted to a coronary care unit because of suspected acute myocardial infarction. Serum 
Increase of CK* isoenzyme MB activity in human serum as an indicator of acute myocardial infarction has been well documented.1-6 Previously reported methods for the determination of CK isoenzymes have most often been based upon either electrophoretic or chromatographic procedures.7-" More recently, radioimmunoassays"2 13 and other immunological procedures14 have been developed. We use an immunoinhibition method for determination of CK B subunit dependent activity in human serum.'5 The application of this immunoinhibition procedure in a group of patients with suspected acute myocardial infarction has been evaluated previously.'6 The aim of the present study was to obtain further data on the diagnostic ability of the serum CK B determination when used as an indicator of acute myocardial infarction. The clinical usefulness of the assay is compared with dependent activity was determined as residual CK activity in the SCE CK reaction system after inmmunoinhibition with a CK M subunit inhibiting antibody (anti-M). 15 In the first 113 cases, serum CK B analyses were performed after storage of the samples at -80'C for up to four months. Total serum CK, however, was determined within 24 hours. In the subsequent 125 patient cases, both total serum CK and serum CK B determinations were carried out within 24 hours.
Control experiments were performed to determine the decrease of serum CK B activity during four months' storage at -80'C. Twenty-four sera, analysed within 24 hours, showed serum CK B activities that ranged from 9 to 146 U/1. They were then stored at -80'C for four months, after which serum CK B activities were redetermined. The decrease in serum CK B activity averaged 9 per cent and was at most 18 per cent in a single sample.
Serum CK and LD isoenzymes were qualitatively estimated by agarose gel electrophoresis at or around peak total activities of serum CK and LD, respectively. Serum CK isoenzymes were evaluated by NADPH fluorescence after the agarose slides had been incubated with the SCE CK reaction medium."' The detection limit for the CK MB isoenzyme with this procedure was approximately 20 to 25 U/1, estimated by electrophoresis of dilutions of known activities from a nearly pure CK MB preparation from human heart tissue. Serum LD isoenzymes were estimated by the tetrazolium method.20 electrophoretic estimations of CK isoenzyme MB and LD isoenzyme H4, respectively, were selected on the basis of a previous study.21 In order to avoid too many false-positive total serum CK results, the acute myocardial infarction discrimination limit for this test was set 40 per cent higher than the upper reference limit in a group of healthy male blood donors.
The diagnostic criterion for the serum AST-ALT relation, hereafter called AST, was that used in the coronary care unit. The acute myocardial infarction discrinmination value for serum CK B activity, determined by the present immunoinhibition method, was selected on the basis of data previously published by us.16 The standard 12 lead electrocardiogram was considered diagnostic of an acute myocardial infarction if one or more of the following characteristics were present: (1) Development of a pathological Q wave in two or more leads. (2) Development, or regression, of a localised ST segment elevation followed by T wave inversion in two or more leads. (3) Development of a pathological R progression in praecordial leads.
CLASSIFICATION OF PATIENTS
Independently of the serum CK B results, patients were classified into acute myocardial infarction and non-acute myocardial infarction groups. For this classification the following three systems were used.
(1) Classification based on the following five tests: (a) total serum CK; (b) serum CK MB (electrophoretic estimation); (c) All but 11 patients were classifiable according to (1) or (2). Among these, there were no discrepancies between the classification systems applied. The 11 remaining cases, constituting 5 per cent of the total patients, were classified according to (3).
The independent ability of the serum CK B determination to classify patients into these groups was then investigated and expressed as predictive values of positive and negative test results (see below). For comparison with serum CK B the discrimination abilities of each of the other enzyme tests and of the electrocardiogram were also assessed. When evaluating tests other than serum CK B, patients were divided into acute myocardial infarction and non-acute myocardial infarction groups according to the classification systems described above. However, when applying system (1) patients were defined as cases of acute myocardial infarction if, without reference to the particular test being evaluated (total serum CK, serum CK MB, serum LD H4, serum AST, and electrocardiogram) at least three of the four remaining tests were positive. Conversely, they were characterised as non-acute case of myocardial infarction if, without reference to the particular test being evaluated, at least three of the four remaining tests were negative. Consequently, serum CK B was never used for classification into acute myocardial infarction and non-acute myocardial infarction groups, as the principal aim of the study was to evaluate this particular test.
PREDICTIVE VALUES OF INDIVIDUAL TESTS
The diagnostic ability of the five enzyme determinations (total CK, CK B, AST, CK MB electro- admitted with chest pain starting one hour before admission. Total serum CK and AST activities had increased rapidly to peak values of about six times their respective discrimination limits, by about 18 and 24 hours, respectively, after the onset of pain. Serum ALT activity was constantly lower than that of serum AST. CK MB was electrophoretically demonstrable at peak total serum CK activity, and serum LD H4 was increased on LD electrophoresis in accord with the diagnosis of acute myocardial infarction. Electrocardiograms showed unequivocal signs of an inferior wall infarct. Serum CK B was in full agreement with the diagnosis of acute myocardial infarction, being rapidly increased to an initial maximal value about seven times the acute myocardial infarction discrimination limit. On the fourth day after admission the patient again suffered repeated attacks of chest pain (arrows in figure) . These attacks were followed by increased activities of serum CK B, total serum CK, and serum AST above their respective discrimination limits. On the fifth day after admission new attacks of chest pain occurred (arrows in figure) . This episode of pain was also followed by distinctly increased activities of serum CK B, total CK, and AST. Consequently, in this case serum CK B, as well as total serum CK and AST, permitted demonstration of three episodes of myocardial enzyme release during seven days. Fig. 3 illustrates the ability of the serum CK B method to distinguish between enzyme release from myocardial and skeletal muscle tissue. A 63-yearold man was admitted with symptoms suggesting acute myocardial infarction during four hours before arrival. According to the criteria described above serum CK, serum CK B, serum AST, and serum LD were increased by factors of about 4, 4, 3, and 2, relative to their respective discrimination limits. Serum ALT constantly remained around the discrimination limit. Shortly after admission, the patient developed ventricular arrhythmias which were treated with procainamide administered intramuscularly at four-hour intervals (arrows in Fig. 3 ). As long as these repeated intramuscular injections were given, total serum CK activity remained high. After the injections were discontinued, total serum CK activity rapidly decreased. Conversely, serum CK B activity was not influenced by the injections, but showed a rapidly decreasing activity after the initial peak.
Comment
The serum CK B curve indicated that enzyme release from injured myocardial tissue ceased early in the course of the disease. Conversely, the prolonged increase of the total serum CK activity probably reflected enzyme release from skeletal muscle after the intramuscular injections. Fig. 4 isoenzyme fraction and a normal LD H4 fraction on LD electrophoresis about 48 hours after the onset of symptoms. On the basis of these enzyme data, the patient was classified as having no acute myocardial infarction. This was supported by the electrocardiographic findings which showed no signs of myocardial injury. Serum CK B, by remaining well below the discrimination limit throughout the observation period, also lent support to this diagnosis. Among other laboratory data, there was a very high S-bilirubin and a biliary tract occlusion was later demonstrated.
CLASSIFICATION OF PATIENTS
According to the criteria for acute myocardial infarction and non-acute myocardial infarction, mentioned above, the total 238 cases were classifiable into 113 with acute myocardial infarction and 125 with non-acute infarction. In 55 patients with acute myocardial infarction with increased activities of serum CK B, total CK, and AST above their respective discrimination limits, we were able to define distinctly the time when the acute symptoms began. The enzyme data of these patients were used to illustrate the probabilities of serum CK B, total CK, and AST being increased above their respective discrimination limits at a certain time after the onset of acute symptoms. Fig. 7 shows the patients with acute myocardial infarction who had CK B activities above the discrimination limit of 12 U/1, as a function of time after the onset of symptoms. Fig. 8 and 9 show the corresponding data for total serum CK and AST, respectively. Serum activities of CK B and total CK of all patients exceeded the discrimination limits within 12 hours after the onset of symptoms. The corresponding time for serum AST was 16 hours. On the other hand, serum activities of CK B and total CK returned to below the respective discrimination limits earlier than 113 Fig. 5 those of AST. This is illustrated in Fig. 7 and 8 by the decreasing number of patients with serum CK B and total serum CK activities above their respective discrimination limits at 22 and 16 hours after the onset of symptoms. For comparison, all patients still had increased serum AST values 36 hours after onset of symptoms (Fig. 9) .
Discussion
As long-term frozen sera were used for determination of serum CK B activities in 113 of the 238 cases, we studied the decrease in serum CK B activity during storage for four months at -800C (see above). One of the patients was a 58-year-old man with cardiac arrest (Fig. 10) . The electrocardiogram on arrival showed ventricular fibrillation. Normal heart action was immediately restored by defibrillation. The patient survived, but remained unconscious for about 20 hours after resuscitation; continuous electrocardiographic monitoring disclosed frequent ventricular arrhythmias. The enzyme data, as shown in Fig. 10 , with serum ALT activity exceeding that of AST activity, total serum CK activity below the acute myocardial infarction discrimination limit, absence of CK MB on CK electrophoresis, and an increased LD M4 fraction together with a normal LD H4 fraction on LD electrophoresis made this patient classifiable as a non-infarction case. This diagnosis was further supported by the electrocardiogram which showed no signs of myocardial damage. The transient serum CK B elevation in the admission sample was a result of the serum CK BB activity, as shown on CK electrophoresis.
We previously described an additional group of patients with CK BB in the serum and consequently increased serum CK B activity.19 In these patients, the BB isoenzyme had an abnormal electrophoretic mobility and was not associated with any known disease. Such patients are recognised by the combination with increased serum CK B activity despite normal, or close to normal, total serum CK activity. In the present patient series, one patient with non-acute myocardial infarction with falsepositive serum CK B result might represent this group. The patient was a 76-year-old woman with a constant slightly increased serum CK B activity of about 12 to 14 U/l in spite of normal total serum CK and other enzyme activities. On serum CK electrophoresis only regularly migrating isoenzyme MM was visible while no isoenzyme band corresponding to the increased serum CK B activity was shown. This, however, might be a consequence of the relatively low serum CK B activity which corresponds to BB isoenzyme activity which may fail to reach the detection limit of the electrophoretic procedure. The remaining false-positive serum CK B result appeared in a patient suffering from repeated attacks of chest pain with concomitant electrocardiographic abnormalities of the Prinzmetal variant angina type. According to the applied classification systems he was classified as a case of non-acute myocardial infarction. However, it is possible that the transient and slight increase in serum CK B activity corresponded to a true but very small myocardial infarction.
The main advantage of the serum CK B analysis, as compared with total serum CK and serum AST determinations, is the increase of the predictive value of a positive test result because of the lower proportion of false-positive results. The relatively poor predictive values of a positive test result of total serum CK and AST mainly reflect the fact that these serum enzyme activities are influenced by many non-cardiac conditions. Thus, total serum CK is often raised after various therapeutic and diagnostic interventions, such as intramuscular injections,34 and cardioversion.3' On the other hand, the predictive values of a negative test result of total CK and AST are similar to that of CK B, indicating the same low proportion of false negative results.
The electrophoretic, qualitative estimations of CK and LD isoenzymes gave about the same predictive values as did serum CK B. The electrophoreses were always performed on one or more samples at or around the peak total activities of the respective enzymes, thus giving optimal test conditions. However, electrophoretic estimation of LD isoenzymes may be particularly useful in patients with delayed admission after the onset of symptoms indicating an acute myocardial infarction. In such cases, the determinations of total serum CK and serum CK B are less suited for the diagnosis of acute myocardial infarction, caused by the transient nature of their serum activity increases after an acute myocardial infarction.36
In conclusion, the serum CK B determination is a test of high clinical specificity and sensitivity in the early diagnosis of acute myocardial infarction. The method is relatively simple and rapid, and is well suited for the routine clinical laboratory.
Note added in proof A complete description of the updated method for serum CK B determination using an improved CK M subunit antibody has recently been published.37
